Pharmaron Beijing Co., Ltd.*

康龍化成(北京)新藥技術股份有限公司

(a joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 3759)

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS OF

THE SECOND SESSION OF THE BOARD

The members of the second session of the board of directors (the "Board") of Pharmaron Beijing Co., Ltd. (the "Company") are set out below:

Executive Directors

Dr. LOU Boliang (chairman of the Board)

Mr. LOU Xiaoqiang

Ms. ZHENG Bei

Non-executive Directors

Mr. CHEN Pingjin

Mr. HU Baifeng

Mr. LI Jiaqing

Mr. ZHOU Hongbin

Independent non-executive Directors

Mr. DAI Lixin

Ms. CHEN Guoqin

Mr. TSANG Kwan Hung Benson

Mr. YU Jian

1

BOARD COMMITTEES UNDER THE SECOND SESSION OF THE BOARD

There are four Board committees under the second session of the Board. The composition of the Board committees is set out in the table below:

Committee

Audit

Remuneration

Nomination

Strategy

and Appraisal

Director

Committee

Committee

Committee

Committee

Dr. LOU Boliang

-

M

M

C

Mr. LOU Xiaoqiang

-

M

-

M

Ms. ZHENG Bei

-

-

M

-

Mr. CHEN Pingjin

-

-

-

M

Mr. HU Baifeng

-

-

-

-

Mr. LI Jiaqing

-

-

-

M

Mr. ZHOU Hongbin

-

-

-

-

Mr. DAI Lixin

-

-

-

M

Ms. CHEN Guoqin

M

C

C

-

Mr. TSANG Kwan Hung Benson

M

M

M

-

Mr. YU Jian

C

M

M

-

Notes:

  1. Chairperson of the relevant Board committees M Member of the relevant Board committees

Beijing, the PRC

July 28, 2020

  • For identification purposes only

2

Attachments

  • Original document
  • Permalink

Disclaimer

Pharmaron Beijing Co. Ltd. published this content on 28 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 July 2020 10:15:04 UTC